iTeos Therapeutics Inc. (ITOS)
NASDAQ: ITOS
· Real-Time Price · USD
10.11
0.00 (0.00%)
At close: Aug 15, 2025, 3:59 PM
10.11
0.05%
After-hours: Aug 15, 2025, 05:36 PM EDT
iTeos Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | 35M | 35M | 23.7M | 23.7M | -11.3M | 1.29M | 66.5M | 85.99M | 127.7M | 267.63M | 454.23M | 539.01M | 497.3M | 344.77M | 104.27M | n/a | n/a |
Cost of Revenue | 626K | 935K | 914K | 1.15M | 1.07M | 958K | 655K | 648K | 627K | 631K | 811K | 748K | 545K | 543K | 489K | 326K | 326K | 126K |
Gross Profit | -35.01M | -323K | -302K | 22.55M | 22.63M | -12.26M | 637K | 65.85M | 85.36M | 127.07M | 266.82M | 453.48M | 538.47M | 496.75M | 344.29M | 103.94M | -326K | -126K |
Operating Income | -221.94M | -152.32M | -159.53M | -150.34M | -144.82M | -173.28M | -150.98M | -93.45M | -65.37M | -19.42M | 126.32M | 322.46M | 417.07M | 384.4M | 244.9M | 16.44M | -76.49M | -55.69M |
Interest Income | 29M | 30.44M | 30.87M | 31.05M | 31.08M | 31.31M | 31.77M | 23.93M | 19.14M | 12.16M | 4.4M | 4.4M | 1.16M | 92K | n/a | n/a | n/a | n/a |
Pretax Income | -190.04M | -118.75M | -122.04M | -116.25M | -106.97M | -134.28M | -111.83M | -58.51M | -26.66M | 14.85M | 148.74M | 350.03M | 424.43M | 389.53M | 256.46M | 17.52M | -65.58M | -46.38M |
Net Income | -202.41M | -130.81M | -134.41M | -121.25M | -108.14M | -135.31M | -112.64M | -61.64M | -28.41M | 11.52M | 96.65M | 261.07M | 329.72M | 297.64M | 214.52M | 14.74M | -65.58M | -46.32M |
Selling & General & Admin | 45.08M | 47.36M | 49.08M | 49.41M | 49.94M | 50.92M | 50.14M | 49.1M | 47.22M | 45.26M | 43.95M | 42.44M | 40.45M | 44.08M | 40.51M | 36.64M | 32.67M | 19.97M |
Research & Development | 160.52M | 139.65M | 144.83M | 135.09M | 128.82M | 121.6M | 112.97M | 110.62M | 104.14M | 101.86M | 97.36M | 89.32M | 81.49M | 68.82M | 59.37M | 51.2M | 43.82M | 35.72M |
Other Expenses | 16.34M | n/a | n/a | n/a | n/a | 326K | 326K | -1.05M | -1.75M | -2.52M | -3.26M | 7.68M | -101K | 398K | 1.38M | -8.47M | 282K | 234K |
Operating Expenses | 221.94M | 187.01M | 193.92M | 184.5M | 178.75M | 171.33M | 161.93M | 157.16M | 148.1M | 144.6M | 138.04M | 128.93M | 118.31M | 106.89M | 89.69M | 78.29M | 65.87M | 46.61M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 2.02M | 2.02M | 2.02M | 2.02M | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | 1K | 1K | 1K | 1K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 221.94M | 187.32M | 194.53M | 185.34M | 179.82M | 172.09M | 162.39M | 157.38M | 148.1M | 144.6M | 138.04M | 128.93M | 118.31M | 106.89M | 89.69M | 78.29M | 65.87M | 46.61M |
Income Tax Expense | 11.88M | 11.57M | 12.38M | 7.39M | 3.96M | 3.83M | 3.61M | 3.54M | 1.75M | 3.33M | 52.08M | 88.96M | 94.71M | 91.78M | 41.82M | 2.65M | -126K | -57K |
Shares Outstanding (Basic) | 43.56M | 43.24M | 40.47M | 43.14M | 39.7M | 35.84M | 35.84M | 35.78M | 35.77M | 35.72M | 35.61M | 37.66M | 37.51M | 38.14M | 35.2M | 35.2M | 35.12M | 34.7M |
Shares Outstanding (Diluted) | 43.56M | 43.24M | 40.47M | 43.14M | 39.7M | 35.84M | 35.84M | 35.78M | 35.77M | 35.72M | 37.88M | 37.66M | 37.64M | 38.14M | 37.48M | 37.48M | 35.12M | 35.09M |
EPS (Basic) | -4.74 | -3.11 | -3.38 | -3.15 | -3 | -3.78 | -3.15 | -1.73 | -0.8 | 0.31 | 2.57 | 7.26 | 9.21 | 8.31 | 6.10 | 0.23 | -2.19 | -1.67 |
EPS (Diluted) | -4.74 | -3.11 | -3.38 | -3.15 | -3 | -3.78 | -3.15 | -1.76 | -0.83 | 0.28 | 2.54 | 6.89 | 8.72 | 7.82 | 5.61 | 0.11 | -2.19 | -1.67 |
EBITDA | -201.67M | -147.93M | -144.41M | -126.97M | -112.89M | -143.07M | -130.2M | -77.24M | -58.83M | -7.85M | 135.24M | 337.1M | 424.75M | 390.02M | 257.15M | 18.25M | -65.05M | -46.01M |
EBIT | -196.62M | -142.85M | -154.32M | -136.79M | -122.64M | -151.32M | -129.7M | -76.72M | -57.39M | -7.8M | 137.6M | 339.53M | 426.28M | 391.61M | 256.28M | 17.33M | -65.87M | -46.61M |
Depreciation & Amortization | 1.29M | 1.26M | 1.24M | 1.15M | 1.07M | 958K | 877K | 870K | 849K | 853K | 811K | 748K | 745K | 743K | 689K | 669K | 611K | 540K |